In This Section

Program

Please note that this meeting will take place as an in-person event in Philadelphia and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the REGISTRATION page for details. 

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise.  Program is subject to change. 

Thursday, September 8

Welcome and Opening Lecture

Friday, September 9

Plenary Session 1: Pathology
Plenary Session 2: Artificial Intelligence
Plenary Session 3: Controversies in Clinical Care (Debate Format)

Saturday, September 10

Plenary Session 4: What is the role of our current surgical treatments?
Plenary Session 5: Imaging
Plenary Session 6: Model Systems

Sunday, September 11

Plenary Session 7:  Molecular Sequencing
Plenary Session 8: Microenvironment

Thursday, September 8

Welcome and Opening Lecture
6:45 p.m.-7:30 p.m.

Welcome from Cochairs

Opening Presentation
Angela M. Belcher, Massachusetts Institute of Technology, Cambridge, Massachusetts

Opening Reception
7:30 p.m.-10:00 p.m.

Friday, september 9

Breakfast
7-8 A.M. 
Plenary Session 1: Pathology
Session Chair: Jorge S. Reis-Filho, Memorial Sloan Kettering Cancer Center, New York, New York 
8-10 A.M. 

Problems in the pathologic diagnosis of ductal carcinoma in situ 
Stuart J. Schnitt, Dana-Farber Cancer Institute, Boston, Massachusetts

DCIS: Pathological heterogeneity and prognosis definition 
Anne Vincent-Salomon, Institut Curie, Paris, France  

Title to be announced
Jorge S. Reis-Filho

Short talks from proffered abstracts

Break
10–10:30 a.m.
Plenary Session 2: Artificial Intelligence
Session Chair: To be announced
10:30 a.m.–12:30 p.m. 

Title to be announced 
Andrew H. Beck, PathAI, Inc., Boston, Massachusetts

Title to be announced 
Yinyin Yuan, Institute for Cancer Research, London, United Kingdom 

Breast pathology and AI: Are we there yet? 
Matthew G. Hanna, Memorial Sloan Kettering Cancer Center, New York, New York  

Short talks from proffered abstracts

Poster Session A/ Lunch (provided)
12:30–2 p.m. 
Plenary Session 3: Controversies in Clinical Care (debate format)  
Moderator: To be announced 
2:30–4:30 p.m.  

Surgery should be done within weeks of diagnosis of DCIS
Jennifer L. Marti, Weill Cornell Medicine, New York, New York
Additional debater to be announced
Discussion

Radiation should be done for all women in the setting of breast conservation to reduce the risk invasive cancer 
Bruce Mann, Royal Melbourne Hospital, Parkville, Australia 
Additional debater to be announced
Discussion

Break/Dinner on own
4:30-7 P.M.
Workshops
7-8 P.M.

Human Tumor Atlas Network Workshop
Chair: Robert West, Stanford University, Stanford, California 

Break
8-8:15 P.M. 
Workshops
8:15-9:15 P.M.

PRECISION Workshop 
Chair: Jelle Wesseling, Netherlands Cancer Institute, Amsterdam, The Netherlands 

Ductal carcinoma in situ: When cancer is not really cancer 
Jelle Wesseling, Netherlands Cancer Institute, Amsterdam, The Netherlands 

Friday September 9

Breakfast
7–8 A.M.
Plenary Session 4: What is the role of our current surgical treatments?
Session Chair: To be announced
8-10 A.M.

Title to be announced
Alistair Thompson, Dan L. Duncan Comprehensive Cancer Center, Houston, Texas

Title to be announced
Seema A. Khan, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois

The evolving role of surgery as precision care for DCIS
E. Shelley Hwang, Duke Cancer Institute, Durham, North Carolina

Short talks selected from proffered abstracts

Break
10-10:30AM
Plenary Session 5: Imaging
Session Chair: To be announced
10:30 A.M.-12:30 P.M.

MR Imaging of active surveillance of DCIS – What we have learned so far
Heather Greenwood, UCSF, San Francisco, California

DCIS and MRI – Challenges and opportunities
Habib Rahbar, University of Washington School of Medicine, Seattle, Washington

Additional speaker to be announced

Short talks from proffered abstracts

Lunch on own
12:30-2:30 P.M.
Plenary Session 6: Model Systems
Session Chair: To be announced
2:30-4:45 P.M.

Title to be announced
Fariba Behbod, University of Kansas Medical Center, Kansas City, Kansas

Title to be announced
Senthil K. Muthuswamy, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Title to be announced
Jos Jonkers, Netherlands Cancer Institute, Amsterdam, The Netherlands

Patient-derived organoids as models for breast cancer interception
Jennifer Rosenbluth, University of California, San Francisco, San Francisco, California

POSTER SESSION B / RECEPTION
4:45-7 P.M.

Sunday, September 11

Breakfast
7-8 A.M.
Plenary Session 7:  Molecular Sequencing
Session Chair: Kornelia Polyak, Dana-Farber Cancer Institute, Boston, Massachusetts
8-9:45 A.M.

Spatial heterogeneity in DCIS
Therese Sørlie, Oslo University Hospital, Oslo, Norway

Title to be announced
Nicholas E. Navin, UT MD Anderson Cancer Center, Houston, Texas

Additional speaker to be announced

Break
9:45-10:15 A.M.
Plenary Session 8: Microenvironment
Session Chair: Lisa Coussens, OHSU Knight Cancer Center, Portland, OR
10:15 A.M.-12 P.M.

Title to be announced
Alexander D. Borowsky, University of California-Davis, Davis, California

Myoepithelial cell differentiation as a harbinger of DCIS progression and potential target for prevention
Pepper Schedin OHSU, Portland, Oregon

Title to be announced
Kornelia Polyak Dana-Farber Cancer Institute, Boston, Massachusetts

Closing Keynote
12:15-1 P.M.
Laura J. Esserman, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
Closing Remarks
1 P.M.